Status:
NOT_YET_RECRUITING
The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM).
Lead Sponsor:
Nanjing First Hospital, Nanjing Medical University
Conditions:
Type1 Diabetes Mellitus
Eligibility:
All Genders
Brief Summary
This study is a multicenter cross-sectional research project, planning to enroll 1000 patients with Type 1 Diabetes Mellitus (T1DM). By reviewing clinical data, physical examinations, questionnaires, ...
Detailed Description
This study is a multicenter cross-sectional research project, planning to enroll 1000 patients with Type 1 Diabetes Mellitus (T1DM). This study will collect multicenter data on T1DM patients, includin...
Eligibility Criteria
Inclusion
- Volunteer to participate and be able to sign informed consent
- Patients with type 1 diabetes
- At least one of the following three clinical characteristics must be met: The disease presents initially with diabetic ketoacidosis (DKA) or ketonuria; The presence of islet-related autoantibodies, such as islet cell antibodies, tyrosine phosphatase antibodies, or glutamic acid decarboxylase (GAD) antibodies, is detected positively; Both fasting and postprandial C-peptide levels are ≤0.6 ng/mL.
Exclusion
- Other types of diabetes.
- Patients who cannot cooperate with the use of continuous glucose monitoring, clinical data collection, and questionnaire completion.
Key Trial Info
Start Date :
November 7 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2027
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06606509
Start Date
November 7 2024
End Date
June 30 2027
Last Update
September 23 2024
Active Locations (101)
Enter a location and click search to find clinical trials sorted by distance.
1
Anqing Municipal Hospital
Anqing, Anhui, China
2
The First Affiliated Hospital of Bengbu Medical University
Bengbu, Anhui, China
3
Hefei First People's Hospital
Hefei, Anhui, China
4
The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China